0001179110-14-013831.txt : 20140909
0001179110-14-013831.hdr.sgml : 20140909
20140909135316
ACCESSION NUMBER: 0001179110-14-013831
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140908
FILED AS OF DATE: 20140909
DATE AS OF CHANGE: 20140909
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celldex Therapeutics, Inc.
CENTRAL INDEX KEY: 0000744218
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 133191702
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 119 FOURTH AVE
CITY: NEEDHAM
STATE: MA
ZIP: 02494
BUSINESS PHONE: 7814330771
MAIL ADDRESS:
STREET 1: 119 FOURTH AVE
CITY: NEEDHAM
STATE: MA
ZIP: 02494-2725
FORMER COMPANY:
FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19980828
FORMER COMPANY:
FORMER CONFORMED NAME: T CELL SCIENCES INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CATLIN AVERY W
CENTRAL INDEX KEY: 0001255348
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15006
FILM NUMBER: 141093004
MAIL ADDRESS:
STREET 1: 241 CENTRAL STREET
CITY: HINGHAM
STATE: MA
ZIP: 02043
4
1
edgar.xml
FORM 4 -
X0306
4
2014-09-08
0
0000744218
Celldex Therapeutics, Inc.
CLDX
0001255348
CATLIN AVERY W
C/O CELLDEX THERAPEUTICS, INC.
53 FRONTAGE ROAD
HAMPTON
NJ
08827
0
1
0
0
Sr. VP & CFO
Common Stock
2014-09-08
4
M
0
10000
4.50
A
24609
D
Incentive Stock Options
4.50
2014-09-08
4
M
0
10000
0.00
D
2013-01-21
2020-01-21
Common Stock
10000
17847
D
As of January 21, 2014, the option was fully vested.
Includes 500 shares acquired under the Celldex Therapeutics, Inc. 2004 Employee Stock Purchase Plan on July 02, 2014.
/s/ Anthony S. Marucci, attorney in fact for Avery W. Catlin
2014-09-09